Wall Street brokerages forecast that Cardiome Pharma Corp (NASDAQ:CRME) (TSE:COM) will announce ($0.19) earnings per share for the current fiscal quarter, according to?Zacks Investment Research.
Zacks Investment Research?lowered shares of?Amarin (NASDAQ:AMRN)?from a hold rating to a sell rating in a research report sent to investors on Wednesday.